This drug inhibits the cancer signalling pathways managed by EGFR by binding the chemical messenger EGFR. That is how the most cancers cells' capacity to develop is proscribed. Erlocip 150 mg (Erlotinib) is amongst the medicines that were used in the treatment method of cancer from the recent